Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II.
We have previously shown that infection with laboratory-passaged strains of influenza virus causes both specific degradation of the largest subunit of the RNA polymerase II complex (RNAP II) and inhibition of host cell transcription. When infection with natural human and avian isolates belonging to different antigenic subtypes was examined, we observed that all of these viruses efficiently induce the proteolytic process. To evaluate whether this process is a general feature of nonattenuated viruses, we studied the behavior of the influenza virus strains A/PR8/8/34 (PR8) and the cold-adapted A/Ann Arbor/6/60 (AA), which are currently used as the donor strains for vaccine seeds due to their attenuated phenotype. We have observed that upon infection with these strains, degradation of the RNAP II does not occur. Moreover, by runoff experiments we observe that PR8 has a reduced ability to inhibit cellular mRNA transcription. In addition, a hypervirulent PR8 (hvPR8) variant that multiplies much faster than standard PR8 (lvPR8) in infected cells and is more virulent in mice than the parental PR8 virus, efficiently induces RNAP II degradation. Studies with reassortant viruses containing defined genome segments of both hvPR8 and lvPR8 indicate that PA and PB2 subunits individually contribute to the ability of influenza virus to degrade the RNAP II. In addition, recently it has been reported that the inclusion of PA or PB2 from hvPR8 in lvPR8 recombinant viruses, highly increases their pathogenicity. Together, the data indicate that the capacity of the influenza virus to degrade RNAP II and inhibit the host cell transcription machinery is a feature of influenza A viruses that might contribute to their virulence.
Rodriguez
Ariel
A
Centro Nacional de Biotecnología, CSIC Darwin 3, Cantoblanco, 28049 Madrid, Spain.
Pérez-González
Alicia
A
Hossain
M Jaber
MJ
Chen
Li-Mei
LM
Rolling
Thierry
T
Pérez-Breña
Pilar
P
Donis
Ruben
R
Kochs
Georg
G
Nieto
Amelia
A
D000818:Animals; D002460:Cell Line; D006801:Humans; D009980:Influenza A virus / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D021122:Protein Subunits / Q000235:genetics / Q000378:metabolism*; D012319:RNA Polymerase II / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012367:RNA, Viral; D014158:Transcription, Genetic
D021122:Protein Subunits; D012333:RNA, Messenger; D012367:RNA, Viral; D012319:RNA Polymerase II
J Biotechnol. 2008 Jan 20;133(2):208-12
17884219
Mol Cell Biol. 2000 Jul;20(14):5077-86
10866664
Virology. 2001 Jul 5;285(2):244-52
11437659
Virology. 2006 Jul 20;351(1):210-7
16624367
Nature. 2009 Apr 16;458(7240):914-8
19194459
Virology. 1998 Dec 20;252(2):324-30
9878611
J Virol. 2009 Jan;83(1):65-72
18945773
J Clin Microbiol. 2005 Nov;43(11):5760-7
16272514
J Virol. 1997 Mar;71(3):2031-40
9032335
J Virol. 1990 Nov;64(11):5669-73
2214032
J Virol. 2005 Dec;79(24):15477-93
16306619
Mol Cell. 1998 Jun;1(7):991-1000
9651582
J Virol. 2000 Sep;74(18):8781-4
10954584
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):588-92
19114663
J Virol. 2001 Sep;75(18):8597-604
11507205
Virology. 2003 Feb 1;306(1):18-24
12620793
J Virol. 2005 Feb;79(4):2191-8
15681421
J Virol. 1988 Feb;62(2):488-95
3336068
Lancet. 1999 Sep 11;354(9182):916-7
10489954
Oncogene. 2006 Mar 16;25(12):1775-85
16314842
Nature. 2005 Oct 6;437(7060):889-93
16208372
EMBO J. 1999 Jul 1;18(13):3767-75
10393191
J Biol Chem. 2005 Sep 9;280(36):31368-77
16012166
J Biol Chem. 2004 Jun 11;279(24):24957-64
15047695
Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1965-73
11779399
J Virol. 1994 Feb;68(2):988-1001
8289400
Virology. 2008 Aug 15;378(1):123-32
18585748
J Virol. 1994 Nov;68(11):6900-9
7933070
Mol Cell Biol. 1988 Oct;8(10):4518-23
2903437
Mol Cell Biol. 1982 Dec;2(12):1644-8
14582206
Arch Virol. 1980;64(2):171-3
7387405
J Clin Microbiol. 1985 Nov;22(5):719-25
4056002
EMBO J. 1999 Apr 15;18(8):2273-83
10205180
J Gen Virol. 1992 Mar;73 ( Pt 3):575-81
1545220
MMWR Recomm Rep. 2004 May 28;53(RR-6):1-40
15163927
Virology. 2004 Jun 20;324(1):184-93
15183065
J Virol. 2005 May;79(9):5812-8
15827195
Cell. 1979 Oct;18(2):329-34
498272
J Virol. 1995 Apr;69(4):2420-6
7884889
Genes Dev. 2006 Nov 1;20(21):2922-36
17079683
Curr Top Microbiol Immunol. 1981;92:25-52
6171385
MMWR Recomm Rep. 2003 Apr 25;52(RR-8):1-34; quiz CE1-4
12755288
Proc Natl Acad Sci U S A. 1978 Oct;75(10):4886-90
283399
Emerg Infect Dis. 2006 Jun;12(6):881-6
16707041
Annu Rev Pathol. 2008;3:499-522
18039138
Genes Dev. 1997 Oct 15;11(20):2645-57
9334327
Cell. 1981 Mar;23(3):847-58
6261960
Nature. 2009 Apr 16;458(7240):909-13
19194458
J Mol Biol. 1999 Jul 30;290(5):929-41
10438593
EMBO J. 1994 Feb 1;13(3):704-12
8313914
Eur J Biochem. 2003 Oct;270(19):3859-70
14511368
J Proteome Res. 2007 Feb;6(2):672-82
17269724
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6806-11
17426143
J Virol. 1996 Mar;70(3):1905-11
8627716
J Virol. 2005 Sep;79(18):11788-800
16140756
J Virol. 2009 Jul;83(13):6673-80
19403683
J Virol. 2003 May;77(10):6007-13
12719592
Avian Dis. 1970 Feb;14(1):66-74
4314007
Arch Virol. 1988;100(3-4):231-44
3401117
J Biol Chem. 2004 Jul 23;279(30):31471-7
15150262
J Mol Biol. 2006 Oct 6;362(5):887-900
16950395
J Virol. 1986 Dec;60(3):1027-39
3023655
J Virol. 2009 Apr;83(8):3944-55
19193801
J Gen Virol. 1992 Jun;73 ( Pt 6):1321-8
1607855
Lancet. 1975 Oct 18;2(7938):729-32
52768
J Biochem. 2007 May;141(5):601-8
17405796
FEBS Lett. 2006 Oct 30;580(25):5851-7
17027977
Avian Dis. 2003;47(3 Suppl):926-30
14575088
Nature. 1981 Jul 2;292(5818):72-5
7278968
J Virol. 2007 May;81(10):5315-24
17344288
J Virol. 2006 May;80(10):5010-20
16641292
Virus Res. 1996 Jun;42(1-2):11-25
8806171
Proteomics. 2008 May;8(10):2077-88
18491320
J Virol. 2006 Apr;80(7):3567-81
16537625